ImmunoBiology
Latest round
- Series C
Last raised
- Jan 2006
Total raised
- $9.5M
Investors
- 5
About ImmunoBiology
Founded in 1999 in Cambridge, UK, ImmunoBiology specializes in immunotherapy and diagnostics. The company has undergone strategic pivots to address emerging healthcare needs.45 million post-money as of August 2012.ImmunoBiology delivers advanced immunotherapies and diagnostic tools aimed at improving health outcomes. Its core offerings are designed to enhance patient care in medical fields such as oncology and infectious diseases. By catering to healthcare providers, the company aims to support better treatment decisions and patient management.4 GBP for the year 2020. The company relies on a revenue model that encompasses partnerships for software licenses and subscriptions, ensuring ongoing support and updates tailored to client needs. The company is focused on enhancing its product portfolio with innovative solutions that meet the evolving demands of the healthcare sector.
Who invested in ImmunoBiology
5 investors across 1 round
See all investors in ImmunoBiology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Jan 23, 2006
Amount
$9.5M
Investors
Questions about ImmunoBiology
Who invested in ImmunoBiology?
ImmunoBiology has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ImmunoBiology raised?
ImmunoBiology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ImmunoBiology last raise money?
ImmunoBiology's most recent round on record is a Series C, in Jan 2006.
What does ImmunoBiology do?
Founded in 1999 in Cambridge, UK, ImmunoBiology specializes in immunotherapy and diagnostics.
Where is ImmunoBiology headquartered?
ImmunoBiology is headquartered in Cambridge, UK.
Which VCs invest in companies like ImmunoBiology?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at ImmunoBiology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like ImmunoBiology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.